Page last updated: 2024-12-08

deacetyltrimepranol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

deacetyltrimepranol: RN given refers to parent cpd; VUFB 6502 is synonymous to HCl [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID162812
SCHEMBL ID21531493
MeSH IDM0048492

Synonyms (17)

Synonym
deacetyltrimepranol
4-[2-hydroxy-3-(propan-2-ylamino)propoxy]-2,3,6-trimethylphenol
57193-14-3
AKOS024326800
desacetylmetipranolol
5ga6i7v01m ,
unii-5ga6i7v01m
vufb 6502
1-(2,3,5-trimethyl-4-hydroxyphenoxy)-3-isopropylamino-2-propanol hydrochloride
phenol, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-2,3,5-trimethyl-, hydrochloride
deacetylmetipranolol
phenol, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-2,3,6-trimethyl-
4-[2-hydroxy-3-(isopropylamino)propoxy]-2,3,6-trimethylphenol
4-(2-hydroxy-3-(isopropylamino)propoxy)-2,3,6-trimethylphenol hydrochloride
Q5263590
SCHEMBL21531493
DTXSID30972645
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (60.00)18.7374
1990's4 (40.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.99

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.99 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.99)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]